Literature DB >> 17715937

Determining antibody stability: creation of solid-liquid interfacial effects within a high shear environment.

James G Biddlecombe1, Alan V Craig, Hu Zhang, Shahid Uddin, Sandrine Mulot, Brendan C Fish, Daniel G Bracewell.   

Abstract

The purpose of this study was to assess the stability of protein formulations using a device designed to generate defined, quantifiable levels of shear in the presence of a solid-liquid interface. The device, based on a rotating disk, produced shear strain rates of up to 3.4 x 10(4) s(-1) (at 250 rps) and was designed to exclude air-liquid interfaces and enable temperature to be controlled. Computational fluid dynamics (CFD) was used to study the fluid flow patterns within the device and to determine the shear strain rate (s(-1)) at a range of disk speeds. The device was then used to study the effect on a monoclonal IgG4 of high levels of shear at the solid-liquid interface. Monomeric antibody concentration and aggregation of the protein in solution were monitored by gel permeation HPLC and turbidity at 350 nm. High shear strain rates were found to cause significant levels of protein aggregation and precipitation with reduction of protein monomer following first-order kinetics. Monomer reduction rate was determined for a range of disk speeds and found to have a nonlinear relationship with shear strain rate, indicating the importance of identifying and minimizing such environments during processing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17715937     DOI: 10.1021/bp0701261

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  11 in total

1.  Adsorptive loss of secreted recombinant proteins in transgenic rice cell suspension cultures.

Authors:  Jun-Young Kwon; Kyoung-Hoon Lee; Su-Hwan Cheon; Hyun-Nam Ryu; Sun Jin Kim; Dong-Il Kim
Journal:  Plant Cell Rep       Date:  2011-11-11       Impact factor: 4.570

Review 2.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

3.  Aggregation and chemical modification of monoclonal antibodies under upstream processing conditions.

Authors:  Stefan Dengl; Marc Wehmer; Friederike Hesse; Florian Lipsmeier; Oliver Popp; Kurt Lang
Journal:  Pharm Res       Date:  2013-01-16       Impact factor: 4.200

Review 4.  Challenges in delivering therapeutic peptides and proteins: A silk-based solution.

Authors:  Junqi Wu; Jugal Kishore Sahoo; Yamin Li; Qiaobing Xu; David L Kaplan
Journal:  J Control Release       Date:  2022-02-11       Impact factor: 11.467

5.  Response of a concentrated monoclonal antibody formulation to high shear.

Authors:  Jared S Bee; Jennifer L Stevenson; Bhavya Mehta; Juraj Svitel; Joey Pollastrini; Robert Platz; Erwin Freund; John F Carpenter; Theodore W Randolph
Journal:  Biotechnol Bioeng       Date:  2009-08-01       Impact factor: 4.530

6.  Aggregation of a monoclonal antibody induced by adsorption to stainless steel.

Authors:  Jared S Bee; Michele Davis; Erwin Freund; John F Carpenter; Theodore W Randolph
Journal:  Biotechnol Bioeng       Date:  2010-01-01       Impact factor: 4.530

7.  Control of protein particle formation during ultrafiltration/diafiltration through interfacial protection.

Authors:  Daniel J Callahan; Bradford Stanley; Yuling Li
Journal:  J Pharm Sci       Date:  2014-01-21       Impact factor: 3.534

8.  Understanding the relationship between biotherapeutic protein stability and solid-liquid interfacial shear in constant region mutants of IgG1 and IgG4.

Authors:  Roumteen Tavakoli-Keshe; Jonathan J Phillips; Richard Turner; Daniel G Bracewell
Journal:  J Pharm Sci       Date:  2013-12-19       Impact factor: 3.534

9.  Using extensional flow to reveal diverse aggregation landscapes for three IgG1 molecules.

Authors:  Leon F Willis; Amit Kumar; John Dobson; Nicholas J Bond; David Lowe; Richard Turner; Sheena E Radford; Nikil Kapur; David J Brockwell
Journal:  Biotechnol Bioeng       Date:  2018-02-04       Impact factor: 4.530

10.  An ultra scale-down method to investigate monoclonal antibody processing during tangential flow filtration using ultrafiltration membranes.

Authors:  Lara Fernandez-Cerezo; Andrea C M E Rayat; Alex Chatel; Jennifer M Pollard; Gary J Lye; Michael Hoare
Journal:  Biotechnol Bioeng       Date:  2019-01-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.